# Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer

> **NCT02031042** · — · COMPLETED · sponsor: **Stockholm South General Hospital** · enrollment: 224 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02031042
- **Lead sponsor:** Stockholm South General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2019-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031042, "Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02031042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
